Utilization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease
McMaster University, Department of Radiation Oncology, Juravinski Cancer Centre, 3rd Floor, 699 Concession Street, Hamilton, Ontario L8V 5C2, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(3), 115-117; https://doi.org/10.3747/co.21.1988
Submission received: 2 March 2014
/
Revised: 3 April 2014
/
Accepted: 4 May 2014
/
Published: 1 June 2014
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
In 2008, cancer overtook cardiovascular disease as the leading cause of death in Canada. [...]
Share and Cite
MDPI and ACS Style
Broomfield, J.A.; Greenspoon, J.N.; Swaminath, A. Utilization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease. Curr. Oncol. 2014, 21, 115-117. https://doi.org/10.3747/co.21.1988
AMA Style
Broomfield JA, Greenspoon JN, Swaminath A. Utilization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease. Current Oncology. 2014; 21(3):115-117. https://doi.org/10.3747/co.21.1988
Chicago/Turabian StyleBroomfield, J.A., J.N. Greenspoon, and A. Swaminath. 2014. "Utilization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease" Current Oncology 21, no. 3: 115-117. https://doi.org/10.3747/co.21.1988
